Kolexia
Roche Bruno Gastro-entérologie
Roche Bruno
Gastro-entérologie
Hôpital Paul Brousse
Villejuif, France
98 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hépatite Hépatite C Hépatite B Cirrhose du foie Hépatite C chronique Fibrose Carcinome hépatocellulaire Maladie du foie en phase terminale Tumeurs du foie

Collaborateurs

Voir plus
Samuel Didier
Samuel Didier
Hôpital Paul Brousse, Villejuif, France
Duclos-Vallee Jean-Charles
Duclos-Vallee Jean-Charles
Hôpital Paul Brousse, Villejuif, France
Coilly Audrey
Coilly Audrey
Hôpital Paul Brousse, Villejuif, France
Sobesky Rodolphe
Sobesky Rodolphe
Hôpital Paul Brousse, Villejuif, France

Industries

Voir plus
A+A
14 collaboration(s)
Dernière en 2021
B3TSI
6 collaboration(s)
Dernière en 2020
M3 Global Research Ltd
3 collaboration(s)
Dernière en 2020
Biotest
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european study (SAVE-D)
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
Abstracts of the 56th A.I.S.F. - Italian Association for theStudy of the Liver - Annual Meeting 2024Rome, March 14th -15th, 2024   01 février 2024
HLA-DQ diversity is associated with humoral response to vaccines in patients awaiting or after liver transplantation.
Gastroenterology   10 janvier 2024
Robotic mesh rectopexy for rectal prolapse: The Geneva technique-A video vignette.
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland   05 novembre 2023
HBV prophylaxis after liver transplantation: close to the full success but at the price of long-term prophylaxis adapted to the risk of HBV recurrence.
Hepatology international   23 juin 2023
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis.
JHEP reports : innovation in hepatology   10 mars 2023
Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival.
Transplantation   26 janvier 2023
Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study.
Annals of transplantation   10 mai 2022
Sacro-coxxygial hygiene, a key factor in the outcome of pilonidal sinus surgical treatment?
BMC surgery   17 avril 2021
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis delta.
Journal of hepatology   04 juillet 2020